Prague Med. Rep. 2020, 121, 209-235
https://doi.org/10.14712/23362936.2020.19
A Review on Role of Arecoline and Its Metabolites in the Molecular Pathogenesis of Oral Lesions with an Insight into Current Status of Its Metabolomics
References
1. , P. V., Kale, A. D., Hallikerimath, S. (2011) Evaluation of myofibroblasts in oral submucous fibrosis: correlation with disease severity. J. Oral Pathol. Med. 40, 208–213.
<https://doi.org/10.1111/j.1600-0714.2010.00995.x>
2. , E., Nery, R. (1969) Mercapturic acid formation during the metabolism of arecoline and arecaidine in rat. Biochem. J. 113, 123–130.
<https://doi.org/10.1042/bj1130123>
3. , E., Nice, E., Williams, K. (1971) The catalysis of nitrosation by thiocyanate from saliva. Food Cosmet. Toxicol. 9(5), 639–643.
<https://doi.org/10.1016/0015-6264(71)90151-9>
4. , T. C., Weeraratna, A. T. (2010) Striking the target in Wnt-y conditions: Intervening in Wnt signalling during cancer progression. Biochem. Pharmacol. 80, 702–711.
<https://doi.org/10.1016/j.bcp.2010.03.002>
5. , M. C., Chan, C. P., Wang, W. T., Chang, B. E., Lee, J. J., Tseng, S. K., Yeung, S. Y., Hahn, L. J., Jeng, J. H. (2013a) Toxicity of areca nut ingredients: Activation of CHK1/CHK2, induction of cell cycle arrest, and regulation of MMP-9 and TIMPs production in SAS epithelial cells. Head Neck 35, 1295–1302.
<https://doi.org/10.1002/hed.23119>
6. , M. C., Lin, L. D., Wu, H. L., Ho, Y. S., Hsien, H. C., Wang, T. M., Jeng, P. Y., Cheng, R. H., Hahn, L. J., Jeng, J. H. (2013b) Areca nut-induced buccal mucosa fibroblast contraction and its signalling: A potential role in oral submucous fibrosis – a precancer condition. Carcinogenesis 34, 1096–1104.
<https://doi.org/10.1093/carcin/bgt012>
7. , Y. C., Yang, S. F., Tai, K. W., Chou, M. Y., Hsieh, Y. S. (2002a) Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol. 38, 195–200.
<https://doi.org/10.1016/S1368-8375(01)00045-8>
8. , Y. C., Tsai, C. H., Tai, K. W., Yang, S. H., Chou, M. Y., Lii, C. K. (2002b) Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis. Oral Oncol. 38, 425–430.
<https://doi.org/10.1016/S1368-8375(01)00083-5>
9. , Y. C., Tsai, C. H., Lai, Y. L., Yu, C. C., Chi, W. Y., Li, J. J., Chang, W. W. (2014) Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1. J. Cell. Mol. Med. 18, 698–708.
<https://doi.org/10.1111/jcmm.12219>
10. , Y. C., Chen, B. C., Yu, C. C., Lin, S. H., Lin, C. H. (2016) miR-19a, -19b, and -26b mediate CTGF expression and pulmonary fibroblast differentiation. J. Cell. Physiol. 231, 2236–2248.
<https://doi.org/10.1002/jcp.25341>
11. , S. L., Jiang, S. S., Wang, Y. J., Chiang, H. C., Chen, P. H., Tu, H. P., Ho, K. Y., Tsai, Y. S., Chang, I. S., Ko, Y. C. (2007) Characterization of arecoline-induced effects on cytotoxicity in normal human gingivial fibroblasts by global gene expression profiling. Toxicol. Sci. 100(1), 66–74.
<https://doi.org/10.1093/toxsci/kfm201>
12. , S., Vickers, E. R., Ghu, S., Zoellner, H. (2010) Salivary arecoline levels during areca nut chewing in human volunteers. J. Oral Pathol. Med. 39, 465–469.
<https://doi.org/10.1111/j.1600-0714.2009.00881.x>
13. , R., Saha, I., Pal, S., Bhattacharyya, A., Sa, G., Nag, T. C., Das, T., Maiti, B. R. (2006) Immunosuppression, hepatotoxicity and depression of antioxidant status by arecoline in albino mice. Toxicology 227, 94–104.
<https://doi.org/10.1016/j.tox.2006.07.016>
14. , S., Chatterjee, A. (1998) Influence of buthionine sulfoximine and reduced glutathione on arecoline-induced chromosomal damage and sister chromatid exchange in mouse bone marrow cells in vivo. Mutagenesis 13, 243–248.
<https://doi.org/10.1093/mutage/13.3.243>
15. , Y. T., Chen, H. M., Cheng, S. J., Chiang, C. P., Kuo, M. Y. P. (2009) Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin. Oral Oncol. 45, e99–e105.
<https://doi.org/10.1016/j.oraloncology.2009.04.004>
16. , A. W., Wickenhauser, C., Salins, P. C., Kappler, M., Bukur, J., Seliger, B. (2016) Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma. J. Transl. Med. 14, 85.
<https://doi.org/10.1186/s12967-016-0828-6>
17. , O., Köhler, E., Reichenberger, F., Bertschin, S., Woodtli, T., Eme, P., Perruchoud, A. P., Roth, M. (1999) Extracellular matrix deposition by primary human lung fibroblasts in response to TGF-beta1 and TGF-beta3. Am. J. Physiol. 276(5), 814–824.
18. , J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., Bray, F. (2015) Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136, E359–E386.
<https://doi.org/10.1002/ijc.29210>
19. , S., Idle, J. R., Chen, C., Zabriskie, T. M., Krausz, K. W., Gonzalez, F. J. (2006) A metabolomic approach to the metabolism of the areca nut alkaloids arecoline and arecaidine in the mouse. Chem. Res. Toxicol. 19(6), 818–827.
<https://doi.org/10.1021/tx0600402>
20. , S., Krausz, K. W., Idle, J. R., Gonzalez, F. J. (2007) The metabolomics of (±)-arecoline 1-oxide in the mouse and its formation by human flavin-containing monooxygenases. Biochem. Pharmacol. 73(4), 561–573.
<https://doi.org/10.1016/j.bcp.2006.10.017>
21. , S., Poindexter, K. M., Sundar, S. N., Firestone, G. L. (2010) Arecoline induced disruption of expression and localization of the tight junctional protein ZO-1 is dependent on the HER 2 expression in human endometrial Ishikawa cells. BMC Cell Biol. 11, 53.
<https://doi.org/10.1186/1471-2121-11-53>
22. , M., Casadio, R., Bergamini, C. M. (2002) Transglutaminases: Nature’s biological glues. Biochem. J. 368, 377–396.
<https://doi.org/10.1042/bj20021234>
23. , W., Scutt, A., Meghji, S., Canniff, J. P. (1986) Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch. Oral Biol. 31(1), 45–49.
<https://doi.org/10.1016/0003-9969(86)90112-3>
24. , T. (1977) Glutathione S-transferases in the metabolism of foreign compounds. Ecotoxicol. Environ. Saf. 1(3), 305–309.
<https://doi.org/10.1016/0147-6513(77)90022-7>
25. , D. F., Biju, M. P., Akai, Y., Wutz, A., Johnson, R. S., Haase, V. H. (2004) Hypoxic induction of Ctgf is directly mediated by Hif-1. Am. J. Physiol. Renal Physiol. 287, 1223–1232.
<https://doi.org/10.1152/ajprenal.00245.2004>
26. , C. M., Hu, F. W., Lee, S. S., Shieh, T. M., Yu, C. H., Lin, S. S., Yu, C. C. (2015) ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas. J. Oral Pathol. Med. 44, 693–698.
<https://doi.org/10.1111/jop.12286>
27. , Y. P., Chen, H. M., Chang, J. Z. C., Chiang, C. P., Deng, Y. T., Kuo, M. Y. P. (2015) Arecoline stimulated early growth response-1 production in human buccal fibroblasts: Suppression by epigallocatechin-3-gallate. Head Neck 37, 493–497.
<https://doi.org/10.1002/hed.23614>
28. , Y. P., Chen, H. M., Lin, H. Y., Yang, H., Chang, J. Z. C. (2017) Epigallocatechin-3-gallate inhibits transforming-growth-factor-β1-induced collagen synthesis by suppressing early growth response-1 in human buccal mucosal fibroblasts. J. Formos. Med. Assoc. 116, 107–113.
<https://doi.org/10.1016/j.jfma.2016.01.014>
29. , Y. H., Liu, W. H., Chen, W., Kuo, Y. C., Hsiao, C. Y., Hung, P. H., Jong, I. C., Chiang, P. C., Hsu, C. C. (2011) Association of betel nut chewing with chronic kidney disease: A retrospective 7-year study in Taiwan. Nephrology (Carlton) 16, 751–757.
<https://doi.org/10.1111/j.1440-1797.2011.01489.x>
30. , F. W., Lee, S. S., Yang, L. C., Tsai, C. H., Wang, T. H., Chou, M. Y., Yu, C. C. (2015) Knockdown of S100A4 impairs arecoline-induced invasiveness of oral squamous cell carcinomas. Oral Oncol. 51, 690–697.
<https://doi.org/10.1016/j.oraloncology.2015.04.003>
31. , W. C., Chang, Y. Z., Wang, H. W., Chao, M. R. (2010) High-throughput simultaneous analysis of five urinary metabolites of areca nut and tobacco alkaloids by isotope-dilution liquid chromatography-tandem mass spectrometry with on line solid phase extraction. Cancer Epidemiol. Biomarkers Prev. 19(10), 2570–2581.
<https://doi.org/10.1158/1055-9965.EPI-10-0483>
32. , L. W., Hsieh, B. S., Cheng, H. L., Hu, Y. C., Chang, W. T., Chang, K. L. (2012) Arecoline decreases interleukin-6 production and induces apoptosis and cell cycle arrest in human basal cell carcinoma cells. Toxicol. Appl. Pharmacol. 258, 199–207.
<https://doi.org/10.1016/j.taap.2011.11.001>
33. , S. P., Yang, M. H., Tseng, K. F., Lee, O. K. (2013) Hypoxia-induced secretion of TGF-β1 in mesenchymal stem cell promotes breast cancer cell progression. Cell Transplant. 22, 1869–1882.
<https://doi.org/10.3727/096368912X657954>
34. , T. C., Huang, L. W., Su, S. J., Hsieh, B. S., Cheng, H. L., Hu, Y. C., Chen, Y. H., Hwang, C. C., Chang, K. L. (2011) Hemeoxygenase-1 expression in response to arecoline-induced oxidative stress in human umbilical vein endothelial cells. Int. J. Cardiol. 151, 187–194.
<https://doi.org/10.1016/j.ijcard.2010.05.015>
35. Working Group on the Evaluation of Carcinogenic Risks to Humans (2004) Betel-quid and areca-nut chewing and some areca-nut-derived nitrosamines. IARC Monogr. Eval. Carcinog. Risks Hum. 85, 1–334.
36. , J. H., Wang, Y. J., Chiang, B. L., Lee, P. H., Chan, C. P., Ho, Y. S., Wang, T. M., Lee, J. J., Hahn, L. J., Chang, M. C. (2003) Roles of keratinocyte inflammation in oral cancer: Regulating the prostaglandin E2, interleukin-6 and TNF-α production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis 24, 1301–1315.
<https://doi.org/10.1093/carcin/bgg083>
37. , W. T., Yang, S. R., Chen, J. Y. F., Cheng, Y. P., Lee, Y. R., Chiang, M. K., Chen, H. R. (2012) Arecoline downregulates levels of p21 and p27 through the reactive oxygen species/mTOR complex 1 pathway and may contribute to oral squamous cell carcinoma. Cancer Sci. 103, 1221–1229.
<https://doi.org/10.1111/j.1349-7006.2012.02294.x>
38. , M. F., Mott, J. D., Finnegan, M. T., Jurukovski, V., Erickson, A. C., Walian, P. J., Taylor, S. E., Ledbetter, S., Lawrence, C. M., Rifkin, D. B., Barcellos-Hof, M. H. (2006) Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radat. Res. 166, 839–848.
<https://doi.org/10.1667/RR0695.1>
39. , S. N., Yang, W. K., Kim, J., Kim, H. S., Kim, E. J., Yun, H., Park, H., Kim, S. S., Choe, W., Kang, I., Ha, J. (2008) Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells. Carcinogenesis 29(4), 713–721.
<https://doi.org/10.1093/carcin/bgn032>
40. , D. (2007) Oral cancer. Mayo Clin. Proc. 82(7), 878–887.
<https://doi.org/10.4065/82.7.878>
41. , S. Y., Wu, C. H., Lin, S. C., Yap, S. K., Chang, C. S., Wong, Y. K., Chi, L. Y., Liu, T. Y. (2002) Genetic polymorphism of cytochrome P4501A1 and susceptibility to oral squamous cell carcinoma and oral precancer lesions associated with smoking/betel use. J. Oral Pathol. Med. 31(9), 505–511.
<https://doi.org/10.1034/j.1600-0714.2002.00158.x>
42. , Y., Quaranta, V. (2009) Cadherin-bound β-catenin feeds into the Wnt pathway upon adherens junction dissociation: Evidence for an intersection between β-catenin pools. PLoS One 4(2), e4580.
<https://doi.org/10.1371/journal.pone.0004580>
43. , V. V., Krishnamurthy, S., Satelur, K. P., Rajkumar, K. (2015) Transforming growth factor-β1 and TGF-β2 act synergistically in the fibrotic pathway in oral submucous fibrosis: An immunohistochemical observation. Indian J. Med. Paediatr. Oncol. 36(2), 111–116.
<https://doi.org/10.4103/0971-5851.158842>
44. , Y. C., Chang, P. Y., Kuo, T. M., Chen, P. K., Lin, Y. Z., Hua, C. H., Chen, Y. C. (2018) Arecoline N-oxide up-regulates caspase-8 expression in oral hyperplastic lesions of mice. J. Agric. Food Chem. 65(47), 10197–10205.
45. , S. K., Williams, D. E. (2005) Mammalian flavin containing monooxygenases: Structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol. Ther. 106(3), 357–387.
<https://doi.org/10.1016/j.pharmthera.2005.01.001>
46. , T. M., Luo, S. Y., Chiang, S. L., Yeh, K. T., Hsu, H. T., Wu, C. T., Lu, C. Y., Tsai, M. H., Chang, J. G., Ko, Y. C. (2015) Fibrotic effects of arecoline N-oxide in oral potentially malignant disorders. J. Agric. Food Chem. 63(24), 5787–5794.
<https://doi.org/10.1021/acs.jafc.5b01351>
47. , S., Xu, J., Derynck, R. (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178–196.
<https://doi.org/10.1038/nrm3758>
48. , C. H., Liu, S. Y., Lin, M. H., Chiang, W. F., Chen, T. C., Huang, W. T., Chou, D. S., Chiu, C. T., Liu, Y. C. (2008) Upregulation of matrix metalloproteinase-1 (MMP-1) expression in oral carcinomas of betel quid (BQ) users: Roles of BQ ingredients in the acceleration of tumour cell motility through MMP-1. Arch. Oral Biol. 53, 810–818.
<https://doi.org/10.1016/j.archoralbio.2008.05.004>
49. , P. H., Chang, M. C., Chang, W. H., Wang, T. M., Wang, Y. J., Hahn, L. J., Ho, Y. S., Lin, C. Y., Jeng, J. H. (2006) Prolonged exposure to arecoline arrested human KB epithelial cell growth: Regulatory mechanisms of cell cycle and apoptosis. Toxicology 220, 81–89.
<https://doi.org/10.1016/j.tox.2005.07.026>
50. , S. S., Tsai, C. H., Ho, Y. C., Chang, Y. C. (2008a) The upregulation of heat shock protein 70 expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Oncol. 44, 884–890.
<https://doi.org/10.1016/j.oraloncology.2007.11.004>
51. , S. S., Yang, S. F., Ho, Y. C., Tsai, C. H., Chang, Y. C. (2008b) The upregulation of metallothionein-1 expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Oncol. 44, 180–186.
<https://doi.org/10.1016/j.oraloncology.2007.01.019>
52. , S. S., Yang, S. F., Tsai, C. H., Chou, M. C., Chou, M. Y., Chang, Y. C. (2008c) Upregulation of heme oxygenase-1 expression in areca-quid-chewing-associated oral squamous cell carcinoma. J. Formos. Med. Assoc. 107, 355–363.
<https://doi.org/10.1016/S0929-6646(08)60100-X>
53. , S. S., Tsai, C. H., Yang, S. F., Ho, Y. C., Chang, Y. C. (2010) Hypoxia inducible factor-1α expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Dis. 16, 696–701.
<https://doi.org/10.1111/j.1601-0825.2010.01680.x>
54. , S. S., Tseng, L. H., Li, Y. C., Tsai, C. H., Chang, Y. C. (2011) Heat shock protein 47 expression in oral squamous cell carcinomas and up-regulated by arecoline in human oral epithelial cells. J. Oral Pathol. Med. 40, 390–396.
<https://doi.org/10.1111/j.1600-0714.2010.00998.x>
55. , S. S., Tsai, C. H., Ho, Y. C., Yu, C. C., Chang, Y. C. (2012a) Heat shock protein 27 expression in areca quid chewing-associated oral squamous cell carcinomas. Oral Dis. 18, 713–719.
<https://doi.org/10.1111/j.1601-0825.2012.01933.x>
56. , S. S., Tsai, C. H., Tsai, L. L., Chou, M. C., Chou, M. Y., Chang, Y. C. (2012b) β-catenin expression in areca quid chewing associated oral squamous cell carcinomas and up-regulated by arecoline in human oral epithelial cells. J. Formos. Med. Assoc. 111, 194–200.
<https://doi.org/10.1016/j.jfma.2010.11.002>
57. , S. S., Tsai, C. H., Yu, C. C., Chang, Y. C. (2013) Elevated snail expression mediates tumor progression in areca quid chewing-associated oral squamous cell carcinoma via reactive oxygen species. PLoS One 8, e67985.
<https://doi.org/10.1371/journal.pone.0067985>
58. , S. S., Chen, Y. J., Tsai, C. H., Huang, F. M., Chang, Y. C. (2015) Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation. Clin. Oral Investig. 20, 1029–1034.
<https://doi.org/10.1007/s00784-015-1579-0>
59. , Y. H., Yang, L. C., Hu, F. W., Peng, C. Y., Yu, C. H., Yu, C. C. (2016) Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis. J. Formos. Med. Assoc. 115, 311–317.
<https://doi.org/10.1016/j.jfma.2015.05.009>
60. , C. H., Yu, M. C., Tung, W. H., Chen, T. T., Yu, C. C., Weng, C. M., Tsai, Y. J., Bai, K. J., Hong, C. Y., Chien, M. H., Chen, B. C. (2013) Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway. Biochim. Biophys. Acta 1833, 2823–2833.
<https://doi.org/10.1016/j.bbamcr.2013.07.016>
61. , K. H., Lin, C. Y., Liu, C. C., Chou, M. Y., Lin, J. K. (2011) Arecoline N-oxide: Its mutagenicity and possible role as ultimate carcinogen in areca oral carcinogenesis. J. Agric. Food Chem. 59(7), 3420–3428.
<https://doi.org/10.1021/jf104831n>
62. , W. T., Shieh, T. M., Yang, L. C., Wang, T. Y., Chou, M. Y., Yu, C. C. (2015) Elevated Lin28B expression is correlated with lymph node metastasis in oral squamous cell carcinomas. J. Oral Pathol. Med. 44, 823–830.
<https://doi.org/10.1111/jop.12314>
63. , G. Y., Storz, P. (2010) Reactive oxygen species in cancer. Free Radic. Res. 44(5), 479–496.
<https://doi.org/10.3109/10715761003667554>
64. , F., Millar, S. E. (2010) Wnt/β-catenin signaling in oral tissue development and disease. J. Dent. Res. 89, 318–330.
<https://doi.org/10.1177/0022034510363373>
65. , S. Y., Liu, Y. C., Huang, W. T., Huang, G. C., Chen, T. C., Lin, M. H. (2007) Up-regulation of matrix metalloproteinase-8 by betel quid extract and arecoline and its role in 2D motility. Oral Oncol. 43, 1026–1033.
<https://doi.org/10.1016/j.oraloncology.2006.11.018>
66. , S. L., Reh, D., Li, A. G., Woods, J., Corless, C. L., Martin, M. K., Wang, X. J. (2004) Overexpression of transforming growth factor-1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res. 64, 4405–4410.
<https://doi.org/10.1158/0008-5472.CAN-04-1032>
67. , E., Durgbanshi, A., Rossi, S., Garcia-Algar, O., Zuccaro, P., Pichini, S. (2005) Determination of arecoline (areca nut alkaloid) and nicotine in hair by high-performance liquid chromatography/electrospray quadrupole mass spectrometry. Rapid Commun. Mass Spectrom. 19, 3416–3418.
<https://doi.org/10.1002/rcm.2183>
68. , S., Charbonneau, M., Grandmont, S., Richard, D. E., Dubois, C. M. (2006) Transforming growth factor β1 induces hypoxia-inducible factor-1 stabilization through selective inhibition of PHD2 expression. J. Biol. Chem. 281(34), 24171–24181.
<https://doi.org/10.1074/jbc.M604507200>
69. , L., Vedrenne, N., Billet, F., Coulomb, B., Darby, I. A., Desmoulière, A. (2012) The myofibroblast, multiple origins for major roles in normal and pathological tissue repair. Fibrogenesis Tissue Repair 5, S5.
<https://doi.org/10.1186/1755-1536-5-S1-S5>
70. , M., Sugawara, E., Yoshimura, T., Yamazaki, H., Kamataki, T. (2005) Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108. Mutat. Res. 581(1–2), 165–171.
<https://doi.org/10.1016/j.mrgentox.2004.12.002>
71. , P. R. O. (2013) Cytochrome P-450-activated prodrugs. Future Med. Chem. 5(2), 213–228.
<https://doi.org/10.4155/fmc.12.197>
72. , K. A., Jenei, V., Sapienza, K., Marsh, D., Weinreb, P. H., Violette, S. M., Lewis, M. P., Marshall, J. F., Fortune, F., Tilakratne, W. M., Hart, I. R., Thomas, G. J. (2011) Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J. Pathol. 223, 366–377.
<https://doi.org/10.1002/path.2786>
73. , R. (1971) The metabolic interconversion of arecoline and arecoline 1-oxide in the rat. Biochem. J. 122(4), 503–508.
<https://doi.org/10.1042/bj1220503>
74. , A., Prokopczyk, B., Rivenson, A., Zang, E., Hoffmann, D. (1992) A study of betel quid carcinogenesis. VIII. Carcinogenicity of 3-(methylnitrosamino)propionaldehyde in F344 rats. Carcinogenesis 13(3), 369–372.
<https://doi.org/10.1093/carcin/13.3.369>
75. , H., Friesen, M., Bartsch, H. (1989) Identification in rats of N-nitrosonipecotic acid as a major urinary metabolite of the areca-nut alkaloid-derived nitrosamines, N-nitrosoguvacoline and N-nitrosoguvacine. Cancer Lett. 44(3), 211–216.
<https://doi.org/10.1016/0304-3835(89)90063-3>
76. , G. B., Rao, A. R. (1984) Induction of in vivo sister chromatid exchanges byarecaidine, a betel nut alkaloid, in mouse bone marrow cells. Cancer Lett. 23(2), 189–192.
<https://doi.org/10.1016/0304-3835(84)90153-8>
77. , C., Rampaul, R. S., Pinder, S. E., Bell, J. A., Wencyk, P. M., Blamey, R. W., Nicholson, R. I., Robertson, J. F. R., Ellis, I. O. (2001) E-cadherin as a prognostic indicator in primary breast cancer. Br. J. Cancer 85, 1958–1963.
<https://doi.org/10.1054/bjoc.2001.2178>
78. , T. A., Kosh, J. W. (1993) Elucidation of the rapid in vivo metabolism of arecoline. Gen. Pharmacol. 24(3), 641–647.
<https://doi.org/10.1016/0306-3623(93)90224-L>
79. , M., Marchei, E., Rossi, S., Vagnarelli, F., Durgbanshi, A., Garcia-Algar, O., Vall, O., Pichini, S. (2007) Liquid chromatography/electrospray ionization tandem mass spectrometry assay for determination of nicotine and metabolites, caffeine and arecoline in breast milk. Rapid Commun. Mass Spectrom. 21, 2693–2703.
<https://doi.org/10.1002/rcm.3137>
80. , W., Liu, Y. J., Wu, N., Sun, T., He, X. Y., Gao, Y. X., Wu, C. J. (2015) Areca catechu L. (Arecaceae): A review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. J. Ethnopharmacol. 164, 340–356.
<https://doi.org/10.1016/j.jep.2015.02.010>
81. , S., Pellegrini, M., Pacifici, R., Marchei, E., Murillo, J., Puig, C., Vall, O., Garcia-Algar, O. (2003) Quantification of arecoline (areca nut alkaloid) in neonatal biological matrices by high-performance liquid chromatography/electrospray quadrupole mass spectrometry. Rapid Commun. Mass Spectrom. 17, 1958–1964.
<https://doi.org/10.1002/rcm.1140>
82. , B., Rivenson, A., Bertinato, P., Brunnemann, K. D., Hoffmann, D. (1987) 3-(Methylnitrosamino)proprionitrile: Occurrence in saliva of betel quid chewers, carcinogenicity, and DNA methylation in F344 rats. Cancer Res. 47(2), 467–471.
83. , B., Bertinato, P., Hoffmann, D. (1988) Cyanoethylation of DNA in vivo by 3-(methylnitrosamino)propionitrile, an Areca-derived carcinogen. Cancer Res. 48(23), 6780–6784.
84. , E. B., Giaccia, A. J. (2016) Hypoxic control of metastasis. Science 352, 175–180.
<https://doi.org/10.1126/science.aaf4405>
85. , A., Ali, S., Lone, M. A., Atif, M., Hassona, Y., Prime, S. S., Pitiyage, G. N., James, E. L. N., Parkinson, E. K. (2016) Areca nut alkaloids induce irreparable DNA damage and senescence in fibroblasts and may create a favourable environment for tumour progression. J. Oral Pathol. Med. 45(5), 365–372.
<https://doi.org/10.1111/jop.12370>
86. , P. A., Philipsen, H. P. (2005) Oral erythroplakia – a review. Oral Oncol. 41, 551–561.
<https://doi.org/10.1016/j.oraloncology.2004.12.003>
87. , K., Kietzmann, T. (2016) Reactive oxygen species and fibrosis: further evidence of a significant liason. Cell Tissue Res. 365, 591–605.
<https://doi.org/10.1007/s00441-016-2445-3>
88. , A., Hoffmann, D., Prokopczyk, B., Amin, S., Hecht, S. S. (1988) Induction of lung and exocrine pancreas tumours in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 48(23), 6912–6917.
89. , C. (2015) Essentials of oral cancer. Int. J. Clin. Exp. Pathol. 8, 11884–11894.
90. , R., Higgins, S. P., Higgins, C. E., Higgins, P. J. (2008) TGF-β1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signalling. J. Mol. Cell. Cardiol. 44, 527–538.
<https://doi.org/10.1016/j.yjmcc.2007.12.006>
91. , D. H., Chiang, L. C., Lee, C. H., Yang, Y. H., Shieh, T. Y. (2004) Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan. J. Oral Pathol. Med. 33, 581–587.
<https://doi.org/10.1111/j.1600-0714.2004.00229.x>
92. , L. P., Menon, M. M., Nair, J., Bhide, S. V. (1983) Correlation of mutagenicity and tumorigenicity of betel quid and its ingredients. Nutr. Cancer 5(2), 87–91.
<https://doi.org/10.1080/01635588309513783>
93. , L. P., Menon, M. M., Bhide, S. V. (1984) Mutagenicity of betel quid and its ingredients using mammalian test systems. Carcinogenesis 5, 501–503.
<https://doi.org/10.1093/carcin/5.4.501>
94. , N. M., D’Souza, A. V., Bhide, S. V. (1980) Effect of betel-quid chewing on nitrite levels in saliva. Food Cosmet. Toxicol. 18(3), 277–281.
<https://doi.org/10.1016/0015-6264(80)90108-X>
95. , L., Diamond, M. E., Ottaviano, A. J., Joseph, M. J., Ananthanarayan, V., Hidayatullah G., Munshi, H. G. (2008) Transforming growth factor-β1 promotes matrix metalloproteinase-9 mediated oral cancer invasion through snail expression. Mol. Cancer Res. 6(1), 10–20.
<https://doi.org/10.1158/1541-7786.MCR-07-0208>
96. , K., Liu, Y., Nair, J., Bartsch, H., Arvidson, K., Grafström, R. C. (1989) Cytotoxic and genotoxic effects of areca nut-related compound in cultured human buccal epithelial cells. Cancer Res. 49, 5294–5298.
97. , G. S., Kondaiah, P. (2009) Regulation of oxidative-stress responsive genes by arecoline in human keratinocytes. J. Periodontal Res. 44, 673–682.
<https://doi.org/10.1111/j.1600-0765.2008.01176.x>
98. , G. S., Agarwal, P., Balapure, A. K., Rao, S. G., Kondaiah, P. (2009) Regulation of extracellular matrix genes by arecoline in primary gingival fibroblasts requires epithelial factors. J. Periodontal Res. 44, 736–743.
<https://doi.org/10.1111/j.1600-0765.2008.01185.x>
99. , W. M., Klinikowski, M. F., Saku, T., Peters, T. J., Warnakuasuriya, S. (2006) Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol. 42, 561–568.
<https://doi.org/10.1016/j.oraloncology.2005.08.005>
100. , Z., Chiba, I., Fujieda, M., Shibata, T., Ariyoshi, N., Yamazaki, H., Sevqican, F., Muthumala, M., Kobayashi, H., Kamataki, T. (2002) CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers in Sri Lanka. Carcinogenesis 23(4), 595–598.
<https://doi.org/10.1093/carcin/23.4.595>
101. , C. C., Ma, R. H., Shieh, T. Y. (1999) Deficiency in collagen and fibronectin phagocytosis by human buccal mucosa fibroblasts in vitro as a possible mechanism for oral submucous fibrosis. J. Oral Pathol. Med. 28(2), 59–63.
<https://doi.org/10.1111/j.1600-0714.1999.tb01997.x>
102. , C. H., Chou, M. Y., Chang, Y. C. (2003) The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: A possible role in the pathogenesis of oral submucous fibrosis. J. Oral Pathol. Med. 32, 146–153.
<https://doi.org/10.1034/j.1600-0714.2003.00004.x>
103. , C. H., Yang, S. F., Chen, Y. J., Chou, M. Y., Chang, Y. C. (2005a) The upregulation of insulin-like growth factor-1 in oral submucous fibrosis. Oral Oncol. 41, 940–946.
<https://doi.org/10.1016/j.oraloncology.2005.05.006>
104. , C. H., Yang, S. F., Chen, Y. J., Chou, M. Y., Chang, Y. C. (2005b) Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and up-regulated by arecoline in human buccal mucosal fibroblasts in vitro. J. Oral Pathol. Med. 34, 100–105.
<https://doi.org/10.1111/j.1600-0714.2004.00288.x>
105. , C. H., Yang, S. F., Chang, Y. C. (2007) The upregulation of cystatin C in oral submucous fibrosis. Oral Oncol. 43, 680–685.
106. , C. H., Yang, S. F., Lee, S. S., Chang, Y. C. (2009) Augmented heme oxygenase-1 expression in areca quid chewing-associated oral submucous fibrosis. Oral Dis. 15, 281–286.
<https://doi.org/10.1111/j.1601-0825.2009.01523.x>
107. , C. H., Lee, S. S., Huang, F. M., Chang, Y. C. (2013) Regulation of protease-activated receptor-1 expression in human buccal fibroblasts stimulated with arecoline. Head Neck 35, 1314–1318.
<https://doi.org/10.1002/hed.23130>
108. , C. H., Lee, S. S., Chang, Y. C. (2015) Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline. J. Oral Pathol. Med. 44, 669–673.
<https://doi.org/10.1111/jop.12284>
109. , Y. P., Wu, K. J. (2012) Hypoxia-regulated target genes implicated in tumor metastasis. J. Biomed. Sci. 19, 102.
<https://doi.org/10.1186/1423-0127-19-102>
110. , Y. S., Lee, K. W., Huang, J. L., Liu, Y. S., Juo, S. H. H., Kuo, W. R., Chang, J. G., Lin, C. S., Jong, Y. J. (2008) Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells. Toxicology 249, 230–237.
<https://doi.org/10.1016/j.tox.2008.05.007>
111. , C. K., Peng, C. H. (1996) The mutagenicities of alkaloids and N-nitrosoguvacoline from betel quid. Mutat. Res. 360, 165–171.
<https://doi.org/10.1016/S0165-1161(96)90013-8>
112. , T. S., Lin, C. P., Chen, Y. P., Chao, M. R., Li, C. C., Liu, K. L. (2018) CYP450-mediated mitochondrial ROS production involved in arecoline N-oxide-induced oxidative damage in liver cell lines. Environ. Toxicol. 33, 1029–1038.
<https://doi.org/10.1002/tox.22588>
113. , Y. C., Tsai, Y. S., Huang, J. L., Lee, K. W., Kuo, C. C., Wang, C. S., Huang, A. M., Chang, J. Y., Jong, Y. J., Lin, C. S. (2010) Arecoline arrests cells at prometaphase by deregulating mitotic spindle assembly and spindle assembly checkpoint: Implication for carcinogenesis. Oral Oncol. 46, 255–262.
<https://doi.org/10.1016/j.oraloncology.2010.01.003>
114. , X. M., Zhang, Y. L., Liu, X. M., Guo, S. X., Wang, H. (2006) Immune responses in mice to arecoline mediated by lymphocyte muscarinic acetylcholine receptor. Cell Biol. Int. 30, 1048–1053.
<https://doi.org/10.1016/j.cellbi.2006.09.015>
115. , G., Hoffmann, D. (1983) A study of betel quid carcinogenesis. I. On the in vitro N-nitrosation of arecoline. Carcinogenesis 4(2), 169–172.
<https://doi.org/10.1093/carcin/4.2.169>
116. , G., Brunnemann, K. D., Hoffmann, D., Bhide, S. V. (1984a) A study of betel quid carcinogenesis. IV. Analysis of the saliva of betel chewers: a preliminary report. J. Cancer Res. Clin. Oncol. 108(1), 110–113.
<https://doi.org/10.1007/BF00390981>
117. , G., Rivenson, A., Hoffmann, D. (1984b) A study of betel quid carcinogenesis. 3. 3-(Methylnitrosamino)-propionitrile, a powerful carcinogen in F344 rats. Carcinogenesis 5(9), 1137–1140.
<https://doi.org/10.1093/carcin/5.9.1137>
118. , I. C., Chen, P. H., Wang, C. J., Wu, D. C., Tsai, S. M., Chao, M. R., Chen, B. H., Lee, H. H., Lee, C. H., Ko, Y. C. (2010) Quantification of blood betel quid alkaloids and urinary 8-hydroxydeoxyguanosine in humans and their association with betel chewing habits. J. Anal. Toxicol. 34, 325–331.
<https://doi.org/10.1093/jat/34.6.325>
119. , S. F., Hsieh, Y. S., Tsai, C. H., Chou, M. Y., Chang, Y. C. (2003) The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol. 39, 367–372.
<https://doi.org/10.1016/S1368-8375(02)00123-9>
120. , S. F., Tsai, C. H., Chang, Y. C. (2008) The upregulation of heat shock protein 47 expression in human buccal fibroblasts stimulated with arecoline. J. Oral Pathol. Med. 37, 206–210.
<https://doi.org/10.1111/j.1600-0714.2007.00633.x>
121. , W. H., Kuo, M. Y., Liu, C. M., Deng, Y. T., Chang, H. H., Chang, J. Z. (2013) Curcumin inhibits TGFβ1-induced CCN2 via Src, JNK, and Smad3 in gingiva. J. Dent. Res. 92, 629–634.
<https://doi.org/10.1177/0022034513488139>
122. , W. H., Deng, Y. T., Hsieh, Y. P., Wu, K. J., Kuo, M. Y. (2016) Thrombin activates latent TGFβ1 via integrin αvβ1 in gingival fibroblasts. J. Dent. Res. 95, 939–945.
<https://doi.org/10.1177/0022034516634288>
123. , C. C., Tsai, C. H., Hsu, H. I., Chang, Y. C. (2013) Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: Involvement in the pathogenesis of oral submucous fibrosis. PLoS One 8, e55122.
<https://doi.org/10.1371/journal.pone.0055122>
124. , J., Cashman, J. R. (2006) Quantitative analysis of FMO gene mRNA levels in human tissues. Drug Metab. Dispos. 34, 19–26.
<https://doi.org/10.1124/dmd.105.006171>
125. , L., Jian, X., Guo, F., Li, N., Jiang, C., Yin, P., Min, A. J., Huang, L. (2015) miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis. Oncol. Rep. 33, 2753–2760.
<https://doi.org/10.3892/or.2015.3909>
126. , Z. S., Li, M., Gao, F., Peng, J. Y., Xiao, H. B., Dai, L. X., Lin, S. R., Zhang, R., Jin, L. Y. (2013) Arecoline suppresses HaCaT cell proliferation through cell cycle regulatory molecules. Oncol. Rep. 29, 2438–2444.
<https://doi.org/10.3892/or.2013.2360>
